z-logo
Premium
Results for Surgical Correction of Complete Atrioventricular Septal Defect: Associations with Age, Surgical Era, and Technique
Author(s) -
Harmandar Bugra,
Aydemir Numan Ali,
Karaci Ali Riza,
Sasmazel Ahmet,
Saritas Turkay,
Bilal Mehmet Salih,
Yekeler Ibrahim
Publication year - 2012
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.12016
Subject(s) - medicine , perioperative , asymptomatic , surgery , atrioventricular valve , atrioventricular septal defect , age groups , heart disease , demography , ventricle , sociology
 Background : This study was conducted to evaluate the outcomes of patients undergoing complete atrioventricular septal defect (CAVSD) repair with particular attention to age at surgery, surgical era, and technique. Methods : One hundred and forty‐seven patients undergoing CAVSD repair between November 2002 and February 2012 were grouped according to surgical era and technique. Group I (age: 9.4 ± 5.0 months; weight: 6.8 ± 1.7 kg) consisted of 45 patients, operated before August 2006, and was divided into subgroup Ia (31 patients; two‐patch repair) and subgroup Ib (14 patients; modified single‐patch repair). One hundred and two patients operated after August 2006 were included in Group II (age: 5.2 ± 3.1 months; weight: 4.9 ± 2.6 kg), and was divided into subgroup IIa (59 patients; two‐patch repair) and subgroup IIb (43 patients; modified single‐patch repair). Groups were compared with regard to perioperative variables and postoperative data. Results : There were 19 early and five late deaths. Overall mortality was significantly higher in Group I, compared to Group II (p < 0.01). Comparison of Groups Ia to Ib and IIa to IIb revealed no statistically significant difference in mortality or morbidity. Age >8 months and preoperative common atrioventricular valve (CAVV) regurgitation ≥ moderate were significant risk factors for mortality and morbidity. After 40.8 ± 24.4 months, 99 (80.4%) of 123 (83.7%) survivors were asymptomatic without any medication, and 24 (19.5%) have mild symptoms. Conclusion : Our current results indicate that younger patient age and better preoperative CAVV functions were the main factors for a favorable outcome after surgical correction of CAVSD; and outcomes did not differ by the surgical technique. (J Card Surg 2012;27:745‐753)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom